Koppula S - Search Results

1

The effects of β-glucans on cancer metastasis.

Yoon TJ, Koppula S, Lee KH. Yoon TJ, et al. Among authors: koppula s. Anticancer Agents Med Chem. 2013 Jun;13(5):699-708. doi: 10.2174/1871520611313050004. Anticancer Agents Med Chem. 2013. PMID: 23140352 Review.

2

NLRP3 Inflammasome Activation Inhibitors in Inflammation-Associated Cancer Immunotherapy: An Update on the Recent Patents.

Kopalli SR, Kang TB, Lee KH, Koppula S. Kopalli SR, et al. Among authors: koppula s. Recent Pat Anticancer Drug Discov. 2018;13(1):106-117. doi: 10.2174/1574892812666171027102627. Recent Pat Anticancer Drug Discov. 2018. PMID: 29076433 Review.

3

MyD88-dependent Toll-like receptor signaling is required for murine macrophages response to IS2.

Li H, Kim WJ, Jiang J, Lee SH, Youn HS, Moon EY, Kim TJ, Ye SK, Ryu JH, Kang TB, Koppula S, Park PJ, Choi DK, Lee KH. Li H, et al. Among authors: koppula s. Int Immunopharmacol. 2011 Oct;11(10):1578-83. doi: 10.1016/j.intimp.2011.05.017. Epub 2011 May 31. Int Immunopharmacol. 2011. PMID: 21628003

4

Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death.

Kumar H, Koppula S, Kim IS, More SV, Kim BW, Choi DK. Kumar H, et al. Among authors: koppula s. CNS Neurol Disord Drug Targets. 2012 Dec;11(8):1015-29. doi: 10.2174/1871527311211080012. CNS Neurol Disord Drug Targets. 2012. PMID: 23244425 Review.

5

Cichorium intybus Linn. Extract Prevents Type 2 Diabetes Through Inhibition of NLRP3 Inflammasome Activation.

Shim DW, Han JW, Ji YE, Shin WY, Koppula S, Kim MK, Kim TK, Park PJ, Kang TB, Lee KH. Shim DW, et al. Among authors: koppula s. J Med Food. 2016 Mar;19(3):310-7. doi: 10.1089/jmf.2015.3556. J Med Food. 2016. PMID: 26987023

6

Anti-inflammatory properties of Morus bombycis Koidzumi via inhibiting IFN-β signaling and NLRP3 inflammasome activation.

Oh NH, Han JW, Shim DW, Sim EJ, Koppula S, Kwak SB, Kim MK, Kim YK, Jiang J, Park PJ, Kang TB, Lee KH. Oh NH, et al. Among authors: koppula s. J Ethnopharmacol. 2015 Dec 24;176:424-8. doi: 10.1016/j.jep.2015.11.022. Epub 2015 Nov 10. J Ethnopharmacol. 2015. PMID: 26571084

7

Novel Small Molecule Inhibitors of Programmed Cell Death (PD)-1, and its Ligand, PD-L1 in Cancer Immunotherapy: A Review Update of Patent Literature.

Kopalli SR, Kang TB, Lee KH, Koppula S. Kopalli SR, et al. Among authors: koppula s. Recent Pat Anticancer Drug Discov. 2019;14(2):100-112. doi: 10.2174/1574892813666181029142812. Recent Pat Anticancer Drug Discov. 2019. PMID: 30370857 Review.

8

Inhibitors of microglial neurotoxicity: focus on natural products.

Choi DK, Koppula S, Suk K. Choi DK, et al. Among authors: koppula s. Molecules. 2011 Jan 25;16(2):1021-43. doi: 10.3390/molecules16021021. Molecules. 2011. PMID: 21350391 Free PMC article. Review.

9

Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson's disease.

Koppula S, Kumar H, More SV, Lim HW, Hong SM, Choi DK. Koppula S, et al. Molecules. 2012 Sep 26;17(10):11391-420. doi: 10.3390/molecules171011391. Molecules. 2012. PMID: 23014498 Free PMC article. Review.

10

Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson's disease.

Koppula S, Kumar H, Kim IS, Choi DK. Koppula S, et al. Mediators Inflamm. 2012;2012:823902. doi: 10.1155/2012/823902. Epub 2012 Apr 22. Mediators Inflamm. 2012. PMID: 22577256 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results